Real-world treatment outcomes from nationwide onco-colon turkey registry in ras wild-type patients treated with biologics first-line metastatic colorectal cancer.

Kefeli, UmutArslan, CagatayYildirim, Mahmut EmreIsikdogan, AbdurrahmanKaradurmus, NuriKarabulut, BulentCubukcu, ErdemCicin, IrfanYalcin, SuayibTurk, Haci M.Bilir, CemilKaraca, MustafaArtac, MehmetSendur, Mehmet NahitAlacacioglu, AhmetSimsek, Eda TanrikuluDane, FaysalBilici, AhmetCevik, DuyguGumus, Mahmut2024-06-242024-06-242021-05-200732-183Xhttps://doi.org/10.1200/JCO.2021.39.15_suppl.e15561https://hdl.handle.net/11452/42264Bu çalışma, 04-08 Haziran 2021 tarihleri arasında düzenlenen Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/openAccessScience & technologyLife sciences & biomedicineOncologyOncologyReal-world treatment outcomes from nationwide onco-colon turkey registry in ras wild-type patients treated with biologics first-line metastatic colorectal cancer.Meeting Abstract0007081203012263915, Supplement S10.1200/JCO.2021.39.15_suppl.e15561